Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

How often do families and doctors clash over life support in the ICU?

NCT ID NCT05768906

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 2 times

Summary

This study looked at how often family members and doctors disagree about decisions to limit life-sustaining treatments in the intensive care unit (ICU). Researchers observed 429 adult ICU patients in France whose treatment was being limited. The goal was to measure the frequency and level of disagreement between relatives and physicians, since such conflicts are becoming more common but are not well documented.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

429 people

The number who actually took part.

Started

Jul 2023

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Life-sustaining therapies limitation decision is made (during the study)

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Consecutive inclusion of all situations in which a life-sustaining therapies limitation decision was made * Patients hospitalized in a French intensive care unit * Age of the patient ≥ 18 years * If relatives are present, age of at least one of the relatives ≥ 18 years NB: situations of "non-re-admission" decisions in intensive care are not taken into account in the inclusion criteria. Exclusion Criteria: * Minor patient * Patient under guardianship * Conscious patient, able to express himself/herself and able to decide jointly with the medical team * Patient for whom a life-sustaining therapies limitation decision was already made prior to ICU admission.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cessation of treatment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Death

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CH Versailles

    Versailles, 78150, France

  • CH d'Aurillac (CH Henri Mondor)

    Aurillac, 15000, France

  • CH de Dieppe

    Dieppe, 76202, France

  • CH de Grasse

    Grasse, 06130, France

  • CH de Lens

    Lens, 62300, France

  • CHBA Vannes-Auray

    Vannes, 56017, France

  • CHU de Clermont Ferrand - Hôpital Gabriel Montpied

    Clermont-Ferrand, 63000, France

  • CHU de Dijon

    Dijon, 21079, France

  • CHU de Grenoble-Alpes

    La Tronche, 38700, France

  • CHU de Montpellier - Gui de Chauliac

    Montpellier, 34295, France

  • CHU de Reims - Réanimation chirurgicale

    Reims, 51092, France

  • CHU de Toulouse-Rangueil - Réanimation Polyvalente

    Toulouse, 31400, France

  • Fondation Ophtalmologique Adolphe de Rothschild

    Paris, 75019, France

  • GHEF (Grand Hôpital de l'Est Francilien)-Site de Marne la Vallée

    Jossigny, 77600, France

  • HIA Robert Picqué

    Villenave-d'Ornon, 33140, France

  • Hôpital Beaujon - Réanimation chirurgicale polyvalente

    Clichy, 92110, France

  • Hôpital Beaujon - Réanimation hépato-digestive

    Clichy, 92110, France

  • Hôpital Lariboisière_APHP - Réanimation Chirurgicale Polyvalente

    Paris, 75010, France

  • Hôpital Saint Camille

    Bry-sur-Marne, 94360, France

  • Hôpital Simone Veil- Eaubonne

    Eaubonne, 95602, France

  • Hôpital privé Claude Galien

    Quincy-sous-Sénart, 91480, France

  • Institut Mutualiste Montsouris -

    Paris, 75014, France

  • Médipôle Lyon Villeurbanne

    Villeurbanne, 69100, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.